The Georgian economy is expected to expand by 3.5% in 2021, rebounding in line with the gradual lifting of the coronavirus (COVID-19) pandemic restrictions and the revival of domestic demand, according to a new Asian Development Bank (ADB) report.
In its Asian Development Outlook (ADO) 2021, the bank’s main annual economic publication, ADB also projected that Georgia’s GDP growth would accelerate to 6% in 2022 as the full reopening of the economy and the expected recovery in tourism boost travel and commerce.
“As a tourism-dependent economy, the gradual lifting of pandemic-related restrictions should revive the country’s growth this year and accelerate it in 2022,” said ADB country director for Georgia Shane Rosenthal. “While the vaccine rollout will be key to a fast recovery, increasing access to finance for small and medium-sized enterprises, expanding e-commerce, and transforming agriculture to boost food exports will be vital to Georgia’s long-term economic growth and the livelihoods of Georgians.”
The ADB projected that inflation would slow to 5.0% in 2021 and 3.5% in 2022, although this would be above the National Bank of Georgia’s inflation target of 3.0%. The current account deficit is expected to narrow to 10% of GDP in 2021 and 7% in 2022 as the merchandise trade balance and tourism gradually improve.
Related Articles
Kuwait sovereign fund sues over London skyscraper that threatens light access
Kuwait's sovereign wealth fund has initiated legal action against one of the City of London's largest development projects, claiming the planned 36-storey tower will obstruct light to a building it ... more
Russian state VTB Bank to divest non-core assets
Russia’s second-largest bank state-controlled VTB plans to divest non-core assets unrelated to banking operations within the next five years, according to Interfax citing the bank's CEO, ... more
Azerbaijani banks report mixed financial performance in Q1 2025
Azerbaijan’s leading commercial banks released their financial results for the first quarter of 2025, showing a mixed performance in profitability, digitalisation, credit growth and capital ... more
Most Read
-
Serbian biotech Dren Bio sold to Sanofi for $1.9bn
1 month ago
-
Scandal surrounding Hungarian central bank’s investments spreads to Polish developer GTC
30 days ago
-
Trump Ukraine envoy Witkoff dismisses Starmer’s Ukraine ceasefire plan, parrots Kremlin talking points
1 month ago
-
Israeli IDF troops engage in ground battle in Syria as airstrikes hit Palmyra
30 days ago
-
COMMENT: Why Iran remains wary of Trump's negotiation overtures
1 month ago